| Recommendations for laparoscopic liver resection: a report from the second international consensus conference held in Morioka G Wakabayashi, D Cherqui, DA Geller, JF Buell, H Kaneko, HS Han, ... Annals of surgery 261 (4), 619-629, 2015 | 1445 | 2015 |
| Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell–and patient-derived tumor organoids L Huang, A Holtzinger, I Jagan, M BeGora, I Lohse, N Ngai, C Nostro, ... Nature medicine 21 (11), 1364-1371, 2015 | 711 | 2015 |
| A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns F Notta, M Chan-Seng-Yue, M Lemire, Y Li, GW Wilson, AA Connor, ... Nature 538 (7625), 378-382, 2016 | 557 | 2016 |
| Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study H Gacaferi, GS Collaborative, COVIDSurg Collaborative Anaesthesia 76 (6), 2021 | 532* | 2021 |
| Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes SA Shah, SP Cleary, AC Wei, I Yang, BR Taylor, AW Hemming, B Langer, ... Surgery 141 (3), 330-339, 2007 | 466 | 2007 |
| Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors SP Cleary, R Gryfe, M Guindi, P Greig, L Smith, R Mackenzie, S Strasberg, ... Journal of the American College of Surgeons 198 (5), 722-731, 2004 | 399 | 2004 |
| Identification of driver genes in hepatocellular carcinoma by exome sequencing SP Cleary, WR Jeck, X Zhao, K Chen, SR Selitsky, GL Savich, TX Tan, ... Hepatology 58 (5), 1693-1702, 2013 | 341 | 2013 |
| Factors predicting response, perioperative outcomes, and survival following total neoadjuvant therapy for borderline/locally advanced pancreatic cancer MJ Truty, ML Kendrick, DM Nagorney, RL Smoot, SP Cleary, RP Graham, ... Annals of surgery 273 (2), 341-349, 2021 | 339 | 2021 |
| Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk ME Croitoru, SP Cleary, N Di Nicola, M Manno, T Selander, M Aronson, ... Journal of the National Cancer Institute 96 (21), 1631-1634, 2004 | 326 | 2004 |
| The extended Toronto criteria for liver transplantation in patients with hepatocellular carcinoma: A prospective validation study G Sapisochin, N Goldaracena, JM Laurence, M Dib, A Barbas, ... Hepatology 64 (6), 2077-2088, 2016 | 320 | 2016 |
| Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium C Bosetti, V Rosato, D Li, D Silverman, GM Petersen, PM Bracci, ... Annals of oncology 25 (10), 2065-2072, 2014 | 317 | 2014 |
| The Toronto General Hospital Transitional Pain Service: development and implementation of a multidisciplinary program to prevent chronic postsurgical pain J Katz, A Weinrib, SR Fashler, R Katznelzon, BR Shah, SSJ Ladak, ... Journal of pain research, 695-702, 2015 | 315 | 2015 |
| Liver transplantation for advanced hepatocellular carcinoma using poor tumor differentiation on biopsy as an exclusion criterion D DuBay, C Sandroussi, L Sandhu, S Cleary, M Guba, MS Cattral, ... Annals of surgery 253 (1), 166-172, 2011 | 313 | 2011 |
| Common variation at 2p13. 3, 3q29, 7p13 and 17q25. 1 associated with susceptibility to pancreatic cancer EJ Childs, E Mocci, D Campa, PM Bracci, S Gallinger, M Goggins, D Li, ... Nature genetics 47 (8), 911-916, 2015 | 257 | 2015 |
| Association of distinct mutational signatures with correlates of increased immune activity in pancreatic ductal adenocarcinoma AA Connor, RE Denroche, GH Jang, L Timms, SN Kalimuthu, I Selander, ... JAMA oncology 3 (6), 774-783, 2017 | 254 | 2017 |
| Germline MutY human homologue mutations and colorectal cancer: a multisite case-control study SP Cleary, M Cotterchio, MA Jenkins, H Kim, R Bristow, R Green, R Haile, ... Gastroenterology 136 (4), 1251-1260, 2009 | 249 | 2009 |
| Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer AP Klein, BM Wolpin, HA Risch, RZ Stolzenberg-Solomon, E Mocci, ... Nature communications 9 (1), 556, 2018 | 224 | 2018 |
| Risk of Colorectal Cancer in Monoallelic and Biallelic Carriers of MYH Mutations: A Population-Based Case-Family Study MA Jenkins, ME Croitoru, N Monga, SP Cleary, M Cotterchio, JL Hopper, ... Cancer Epidemiology Biomarkers & Prevention 15 (2), 312-314, 2006 | 223 | 2006 |
| Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancer AK Win, JG Dowty, SP Cleary, H Kim, DD Buchanan, JP Young, ... Gastroenterology 146 (5), 1208-1211. e5, 2014 | 221 | 2014 |
| Integration of genomic and transcriptional features in pancreatic cancer reveals increased cell cycle progression in metastases AA Connor, RE Denroche, GH Jang, M Lemire, A Zhang, ... Cancer cell 35 (2), 267-282. e7, 2019 | 171 | 2019 |
